Alnylam Pharmaceuticals Inc
XETRA:DUL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Alnylam Pharmaceuticals Inc
XETRA:DUL
|
US |
|
R
|
Royal Bank of Canada
SWB:RYC
|
CA |
|
I
|
Informa PLC
OTC:IFPJF
|
UK |
|
Upstart Holdings Inc
NASDAQ:UPST
|
US |
|
P
|
Paychex Inc
F:PCX
|
US |
|
Jiangxi Copper Co Ltd
F:JIX
|
CN |
|
Barsele Minerals Corp
XTSX:BME
|
CA |
|
A
|
AT&T Inc
DUS:SOBA
|
US |
|
I
|
Iron Mountain Inc
F:I5M
|
US |
|
Rockwool A/S
F:R902
|
DK |
|
Derichebourg SA
F:PNU
|
FR |
|
T
|
TTL Beteiligungs und Grundbesitz AG
DUS:TTO
|
DE |
|
Baozun Inc
F:2BZ
|
CN |
|
M
|
Mediobanca Banca di Credito Finanziario SpA
DUS:ME9
|
IT |
|
MTR Corp Ltd
OTC:MTCPY
|
HK |
Intrinsic Value
The intrinsic value for 
Alnylam Pharmaceuticals Inc (DUL) under the Base Case is hidden
EUR.
Compared with the current market price of 110.36 EUR, the stock appears hidden
.
DUL looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if DUL is one of them.
Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Alnylam Pharmaceuticals Inc.
Fundamental Analysis
Revenue & Expenses Breakdown
Alnylam Pharmaceuticals Inc
Earnings Waterfall
Alnylam Pharmaceuticals Inc
The intrinsic value for Alnylam Pharmaceuticals Inc (DUL) under the Base Case is hidden EUR.
Compared with the current market price of 110.36 EUR, the stock appears hidden.
